Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qian-Qian Ju

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Sheng Li Xue Bao : [Acta Physiologica Sinica]|April 21, 2026
[Research progress on protein succination modification in cancer]Qian-Qian Ju, Cheng Sun
Annals of Hematology|June 24, 2026
Predicting response to hypomethylating agents in myeloid neoplasms: a robust modelChao Guo, Ya-Yue Gao, Qian-Qian Ju, et al.
BMC Cancer|September 5, 2020
LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemiaChao Guo, Ya-Yue Gao, Qian-Qian Ju, et al.
BMC Cancer|June 24, 2020
Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemiaChao Guo, Qian-Qian Ju, Chun-Xia Zhang, et al.
Journal of Translational Medicine|January 24, 2021
HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemiaChao Guo, Ya-Yue Gao, Qian-Qian Ju, et al.
Journal of Translational Medicine|May 30, 2021
The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AMLChao Guo, Ya-Yue Gao, Qian-Qian Ju, et al.
Journal of Translational Medicine|June 1, 2021
MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomesChao Guo, Ya-Yue Gao, Qian-Qian Ju, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Sheng Li Xue Bao : [Acta Physiologica Sinica]|April 21, 2026
[Research progress on protein succination modification in cancer]Qian-Qian Ju, Cheng Sun
Annals of Hematology|June 24, 2026
Predicting response to hypomethylating agents in myeloid neoplasms: a robust modelChao Guo, Ya-Yue Gao, Qian-Qian Ju, et al.
BMC Cancer|September 5, 2020
LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemiaChao Guo, Ya-Yue Gao, Qian-Qian Ju, et al.
BMC Cancer|June 24, 2020
Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemiaChao Guo, Qian-Qian Ju, Chun-Xia Zhang, et al.
Journal of Translational Medicine|January 24, 2021
HELQ and EGR3 expression correlate with IGHV mutation status and prognosis in chronic lymphocytic leukemiaChao Guo, Ya-Yue Gao, Qian-Qian Ju, et al.
Journal of Translational Medicine|May 30, 2021
The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AMLChao Guo, Ya-Yue Gao, Qian-Qian Ju, et al.
Journal of Translational Medicine|June 1, 2021
MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomesChao Guo, Ya-Yue Gao, Qian-Qian Ju, et al.
Pageof 1